G van Soest

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi 3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification
    Takayuki Okamura
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:836-44. 2010
  2. ncbi Frequency domain multiplexing for speckle reduction in optical coherence tomography
    Gijs van Soest
    Thorax Center, Erasmus MC, Rotterdam, The Netherlands
    J Biomed Opt 17:076018. 2012
  3. ncbi Robust intravascular optical coherence elastography by line correlations
    Gijs van Soest
    Department of Biomedical Engineering, Thorax Center, Erasmus MC, PO Box 2040, NL 3000 CA Rotterdam, The Netherlands
    Phys Med Biol 52:2445-58. 2007
  4. ncbi Azimuthal registration of image sequences affected by nonuniform rotation distortion
    Gijs van Soest
    Department of Biomedical Engineering, Thorax Center, Erasmus Medical Center, Rotterdam, The Netherlands
    IEEE Trans Inf Technol Biomed 12:348-55. 2008
  5. ncbi Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging
    Gijs van Soest
    Erasmus Medical Center, Thorax Center, Rotterdam, The Netherlands
    J Biomed Opt 15:011105. 2010
  6. ncbi Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries)
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 96:358-62. 2005
  7. ncbi The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Dr. Molewaterplein 40, 3015-GD Rotterdam, The Netherlands
    J Am Coll Cardiol 45:1135-41. 2005
  8. ncbi Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RES
    Marco Valgimigli
    Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 111:1383-9. 2005
  9. ncbi Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study
    Nico Bruining
    Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:449-56. 2010
  10. ncbi Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease
    Cihan Simsek
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 76:41-9. 2010

Detail Information

Publications86

  1. ncbi 3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification
    Takayuki Okamura
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:836-44. 2010
    ..The purpose of this study is to assess jailing of side branches (SB) by the everolimus-eluting, bioresorbable vascular scaffold (BVS) with 3-dimensional (3D) optical coherence tomography (OCT) reconstruction...
  2. ncbi Frequency domain multiplexing for speckle reduction in optical coherence tomography
    Gijs van Soest
    Thorax Center, Erasmus MC, Rotterdam, The Netherlands
    J Biomed Opt 17:076018. 2012
    ..We demonstrate this technique using intravascular optical frequency domain imaging data acquired in vivo...
  3. ncbi Robust intravascular optical coherence elastography by line correlations
    Gijs van Soest
    Department of Biomedical Engineering, Thorax Center, Erasmus MC, PO Box 2040, NL 3000 CA Rotterdam, The Netherlands
    Phys Med Biol 52:2445-58. 2007
    ..55 microm, and the rms error of the strain is 0.6%. It is shown that high-strain spots in the vessel wall, such as observed at the sites of vulnerable atherosclerotic lesions, can be detected with the technique...
  4. ncbi Azimuthal registration of image sequences affected by nonuniform rotation distortion
    Gijs van Soest
    Department of Biomedical Engineering, Thorax Center, Erasmus Medical Center, Rotterdam, The Netherlands
    IEEE Trans Inf Technol Biomed 12:348-55. 2008
    ..The algorithm can be adapted to ingest data frame-by-frame, and can be implemented to work in real time...
  5. ncbi Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging
    Gijs van Soest
    Erasmus Medical Center, Thorax Center, Rotterdam, The Netherlands
    J Biomed Opt 15:011105. 2010
    ..The algorithm is successfully applied to OCT patient data, demonstrating that the analysis can be used in a clinical setting and assist diagnostics of vessel wall pathology...
  6. ncbi Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries)
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 96:358-62. 2005
    ..Patients who required insulin had a significantly higher, crude major adverse cardiac event rate at 1 year compared with those who used oral agents, but this rate became nonsignificant when adjusted for independent predictors of outcome...
  7. ncbi The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Dr. Molewaterplein 40, 3015-GD Rotterdam, The Netherlands
    J Am Coll Cardiol 45:1135-41. 2005
    ..The inferior trend in crude outcome seen in PES was due to its higher-risk population. A larger, randomized study enrolling an unselected population may assist in determining the relative superiority of either device...
  8. ncbi Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RES
    Marco Valgimigli
    Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 111:1383-9. 2005
    ....
  9. ncbi Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study
    Nico Bruining
    Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:449-56. 2010
    ....
  10. ncbi Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease
    Cihan Simsek
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 76:41-9. 2010
    ..There are limited data on the long-term safety and efficacy profile of coronary stent implantation in patients with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI)...
  11. ncbi Compositional volumetry of non-calcified coronary plaques by multislice computed tomography: an ex vivo feasibility study
    Nico Bruining
    Department of Cardiology, Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 5:558-64. 2009
    ..This study explores the application to use the Hounsfield units (HU) distribution of coronary plaques imaged by multislice computed tomography-coronary angiography (MSCT-CA)...
  12. ncbi Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis
    Marco Valgimigli
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    J Am Coll Cardiol 47:507-14. 2006
    ..36) and 0.52 +/- 0.42 (p = 0.41) in the PES group, respectively. CONCLUSIONS: In consecutive patients undergoing percutaneous LM intervention, PES may perform closely to SES both in terms of angiographic and long-term clinical outcome...
  13. ncbi In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial
    Takayuki Okamura
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 5:932-8. 2010
    ..1) were introduced for the ABSORB Cohort B study in order to decrease recoil. The aim was to compare in vivo the strut distribution between the BVS revision 1.0 (Cohort A), and BVS revision 1.1 (Cohort B) designs...
  14. ncbi Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/un
    Nieves Gonzalo
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:445-52. 2009
    ....
  15. ncbi In vivo relationship between compositional and mechanical imaging of coronary arteries. Insights from intravascular ultrasound radiofrequency data analysis
    Gaston A Rodriguez-Granillo
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Am Heart J 151:1025.e1-6. 2006
    ..We sought to explore in vivo the relation between mechanical and compositional properties of matched cross sections (CSs) using novel catheter-based techniques...
  16. ncbi Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical tri
    Hector M Garcia-Garcia
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 4:443-8. 2009
    ....
  17. ncbi "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions
    Jiro Aoki
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am Heart J 150:994-9. 2005
    ..CONCLUSIONS: The use of DES for the treatment of diffuse lesions was associated with a low rate of repeat revascularization, irrespective of stent type. No safety concerns were raised at medium-term follow-up...
  18. ncbi Optical coherence tomography in patients with acute coronary syndrome
    Evelyn Regar
    Thoraxcenter, Department of Interventional Cardiology, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:G154-60. 2010
    ....
  19. ncbi MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Ba 583, s Gravendijkwal 230, Rotterdam, The Netherlands
    Eur Heart J 30:1477-85. 2009
    ..To report the 4-month angiographic and 6-month clinical follow-up in first-in-man study using the tacrolimus-eluting bioabsorbable polymer-coated cobalt-chromium MAHOROBA stent...
  20. ncbi Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents
    Keiichi Tsuchida
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 96:395-8. 2005
    ..5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations...
  21. ncbi Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam
    Marco Valgimigli
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    J Am Coll Cardiol 47:1530-7. 2006
    ..CONCLUSIONS: Distal LMCA disease carries independent prognostic implications, and it may help in selecting the most appropriate patient subset for LMCA intervention beyond the conventional surgical risk status in the DES era...
  22. ncbi First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography
    Takayuki Okamura
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:1037-45. 2011
    ..The Terumo-OFDI system is capable of acquiring images with high-speed automated pullback (up to 40 mm/sec) and requires only a short injection (3-4 sec) of small amount of x-ray contrast (9-16 ml)...
  23. ncbi 6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
    Roberto Diletti
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 58:258-64. 2011
    ..We investigated the 6-month clinical outcomes after implantation of second-generation 3.0-mm bioresorbable everolimus-eluting vascular scaffolds (BVS) in small coronary vessels (<2.5 mm)...
  24. ncbi Multi-modality intra-coronary plaque characterization: a pilot study
    Nieves Gonzalo
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Int J Cardiol 138:32-9. 2010
    ....
  25. ncbi A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds
    Josep Gomez-Lara
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Eur Heart J 32:294-304. 2011
    ..0. This study sought to evaluate the differences in late shrinkage, neointimal response, and bioresorption process between these two scaffold generations using optical coherence tomography (OCT)...
  26. ncbi A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents
    Josep Gomez-Lara
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:1190-8. 2010
    ..The aim of this study was to assess the differences in terms of curvature and angulation of the treated vessel after the deployment of either a metallic stent or a polymeric scaffold device...
  27. ncbi Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis
    Michael Magro
    Department of Interventional Cardiology, Thoraxcenter, Erasmus University MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 77:798-806. 2011
    ..Objective: To report acute procedural and six month clinical follow-up after the use of the Tryton Sidebranch stent in an "all comer" registry...
  28. ncbi Late angiographic stent thrombosis (LAST) events with drug-eluting stents
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Dr. Molewaterplein 40, 3015-GD Rotterdam, The Netherlands
    J Am Coll Cardiol 45:2088-92. 2005
    ..35% (95% confidence limits 0.17% to 0.72%) in patients treated with DES. Importantly, it may also occur when patients are stable on antiplatelet monotherapy...
  29. ncbi Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry
    Jiro Aoki
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:1574-9. 2005
    ..Further developments in this technology are warranted to evaluate the efficacy of this device for the treatment of coronary artery disease...
  30. ncbi Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:947-53. 2005
    ..Stent thrombosis was associated with a high morbidity and mortality. Bifurcation stenting, when performed in patients with acute myocardial infarction, was associated with an increased risk of ST...
  31. ncbi Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation
    Gaston A Rodriguez-Granillo
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am Heart J 151:1020-24. 2006
    ..The purpose of this study was to assess the relationship between plaque composition determined by intravascular ultrasound (IVUS) radio frequency (RF) data analysis and clinical presentation...
  32. ncbi Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT
    Roberto Diletti
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Imaging 4:774-80. 2011
    ..The aim of this study was to evaluate the progression of atherosclerotic coronary plaques at bifurcations, using combined intravascular ultrasound-virtual histology (IVUS-VH) and optical coherence tomography (OCT)...
  33. ncbi Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries
    Nieves Gonzalo
    Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, Paises Bajos
    Rev Esp Cardiol 62:615-24. 2009
    ..The objectives were to compare the lumen measurements obtained ex vivo in human coronary arteries using IVUS, OCT and histomorphometry, and in vivo in patients using IVUS and OCT with and without balloon occlusion...
  34. ncbi Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography
    Josep Gomez-Lara
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 4:992-1001. 2011
    ....
  35. ncbi In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography
    Nieves Gonzalo
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Imaging 2:473-82. 2009
    ..e., necrotic core rich) at bifurcations using a combined plaque assessment with intravascular ultrasound-virtual histology (IVUS-VH) and optical coherence tomography (OCT)...
  36. ncbi Retrospective image-based gating of intracoronary optical coherence tomography: implications for quantitative analysis
    Kenji Sihan
    Thoraxcentre, Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:1098-103. 2011
    ....
  37. ncbi Global characterization of coronary plaque rupture phenotype using three-vessel intravascular ultrasound radiofrequency data analysis
    Gaston A Rodriguez-Granillo
    Department of Cardiology, Thoraxcenter, Erasmus MC, Bd 406, Dr Molewaterplein 40, PO Box 1738, 3015 GD Rotterdam, The Netherlands
    Eur Heart J 27:1921-7. 2006
    ....
  38. ncbi Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions
    Muzaffer Degertekin
    Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Bd. 48, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur Heart J 25:32-8. 2004
    ..CONCLUSION: Sirolimus-eluting stenting is equally effective at inhibiting neointimal proliferation in de novo and ISR lesions without inducing edge restenosis or positive vascular remodelling...
  39. ncbi Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound
    Carlos A G van Mieghem
    Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circulation 114:645-53. 2006
    ..MSCT is safe to exclude left main ISR and may therefore be an acceptable first-line alternative to CCA...
  40. ncbi IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process
    Giovanna Sarno
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 75:914-8. 2010
    ..Aim of this study was therefore to evaluate the dynamic changes in plaque size and plaque tissue composition observed between 6 months and 2 years follow-up, and to compare these findings to the prestenting phase...
  41. ncbi A multicentre evaluation of the safety of intracoronary optical coherence tomography
    Peter Barlis
    Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands
    EuroIntervention 5:90-5. 2009
    ..The purpose of the present multicentre registry was to assess the acute complications associated with the clinical use of intra-coronary OCT in a large number of patients...
  42. ncbi Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
    Giovanna Sarno
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 6:977-84. 2011
    ....
  43. ncbi Computed tomography as a tool for percutaneous coronary intervention of chronic total occlusions
    Michael Magro
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:G123-31. 2010
    ..It is then that we can evaluate the true benefit of the use of MSCT for CTO against the risk from excessive radiation associated with this strategy...
  44. ncbi First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era?
    Steve Ramcharitar
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam 3015 GD, The Netherlands
    Nat Rev Cardiol 6:374-8. 2009
    ..A 63-year-old man presented with class II anginal symptoms...
  45. ncbi Diagnosis and treatment of coronary vulnerable plaques
    Hector M Garcia-Garcia
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Expert Rev Cardiovasc Ther 6:209-22. 2008
    ..Very rigorous and well-designed studies are compelling for defining the role of each diagnostic modality. Until we are able to detect in vivo vulnerable plaques accurately, no specific treatment is warranted...
  46. ncbi Current diagnostic modalities for vulnerable plaque detection
    Johannes A Schaar
    Erasmus MC Rotterdam, Thoraxcenter, Dr Molewaterplein 50, Room Ee 23 32, NL 3000 DR Rotterdam, Rotterdam, The Netherlands
    Curr Pharm Des 13:995-1001. 2007
    ..Most of the techniques show exiting features, but none have proven their value in an extensive in vivo validation and all have a lack of prospective data...
  47. ncbi A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
    Patrick W Serruys
    Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands
    Lancet 373:897-910. 2009
    ..We assessed the safety of the bioabsorbable everolimus-eluting stent (BVS)...
  48. ncbi Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomo
    Yoshinobu Onuma
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Circulation 122:2288-300. 2010
    ..We therefore report OCT findings with corresponding histology in the porcine coronary artery model immediately after and at 28 days and 2, 3, and 4 years after BVS implantation...
  49. ncbi Reproducibility of quantitative optical coherence tomography for stent analysis
    Nieves Gonzalo
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 5:224-32. 2009
    ..To assess the inter- and intra- observer reproducibility for strut count, strut apposition and strut tissue coverage measurements with optical coherence tomography (OCT)...
  50. ncbi Incidence of high-strain patterns in human coronary arteries: assessment with three-dimensional intravascular palpography and correlation with clinical presentation
    Johannes A Schaar
    Erasmus Medical Center, Thoraxcenter Rotterdam, Kamer Ee 23 32, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Circulation 109:2716-9. 2004
    ..We further explored the relation of such regions to clinical presentation and to C-reactive protein levels...
  51. ncbi Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Yosinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 6:447-53. 2010
    ..Nevertheless, the long-term safety and efficacy of this novel therapy remain to be documented...
  52. ncbi Intravascular palpography for high-risk vulnerable plaque assessment
    Johannes A Schaar
    Thorax Center, Erasmus Medical Center, Rotterdam, The Netherlands
    Herz 28:488-95. 2003
    ..The stress in the cap increases with decreasing cap thickness and increasing macrophage infiltration. Intravascular ultrasound (IVUS) palpography might be an ideal technique to assess the mechanical properties of high-risk plaques...
  53. ncbi NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography
    Salvatore Brugaletta
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Imaging 4:647-55. 2011
    ....
  54. ncbi Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound
    Muzaffer Degertekin
    Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 91:1046-50. 2003
    ..In the SES group, 1 patient (4%) showed late acquired incomplete stent apposition. Thus, the SES is effective in inhibiting neointimal hyperplasia without affecting vessel volume and plaque behind the stent...
  55. ncbi Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages
    Takayuki Okamura
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:371-9. 2010
    ..We tested the reproducibility of in vivo, intracoronary FD OCT and assessed the influence of different computer-assisted algorithms on quantitative analysis...
  56. ncbi Optical coherence tomography patterns of stent restenosis
    Nieves Gonzalo
    Thoraxcenter, Erasmus MC, Rotterdam 3015 CE, The Netherlands
    Am Heart J 158:284-93. 2009
    ..Stent restenosis is an infrequent but poorly understood clinical problem in the drug-eluting stent era. The aim of the study was to evaluate the morphologic characteristics of stent restenosis by optical coherence tomography (OCT)...
  57. ncbi Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
    Josep Gomez-Lara
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 4:1271-80. 2011
    ..This study sought to compare the neointimal response of metallic everolimus drug-eluting stents (DES) and polymeric everolimus bioresorbable vascular scaffolds (BVS) by optical coherence tomography at 1 year...
  58. ncbi The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 54:269-76. 2009
    ....
  59. ncbi Geometrical validation of intravascular ultrasound radiofrequency data analysis (Virtual Histology) acquired with a 30 MHz boston scientific corporation imaging catheter
    Gaston A Rodriguez-Granillo
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 66:514-8. 2005
    ..These results suggest that ultrasound radiofrequency data analysis could provide, aside from precise compositional data, an accurate geometrical output...
  60. ncbi Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment
    Nieves Gonzalo
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 5:D93-D100. 2009
    ..In this article we perform a review of current developments and evidence in this area...
  61. ncbi Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy
    Joanna J Wykrzykowska
    The Department of Interventional Cardiology Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 5:310-7. 2009
    ..In this substudy of the LEADERS trial, we compared the performance of biolimus biodegradable polymer (BES) and sirolimus permanent polymer stents (SES) in long lesions...
  62. ncbi Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy
    Francesco Saia
    Erasmus MC, Thoraxcenter, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Am J Cardiol 92:200-3. 2003
  63. ncbi Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies
    Gaston A Rodriguez-Granillo
    Department of Interventional Cardiology of the Erasmus Medical Center, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 22:621-31. 2006
    ..The purpose of this study was to assess in vivo the reproducibility of tissue characterization using spectral analysis of intravascular ultrasound (IVUS) radiofrequency data (IVUS-VH)...
  64. ncbi Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods
    Francesco Saia
    Department of Interventional Cardiology, Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands
    J Cardiovasc Med (Hagerstown) 7:21-8. 2006
    ..This current perspective describes the recently developed invasive imaging techniques to detect atherosclerotic vulnerable plaques in the coronary tree...
  65. ncbi Second-generation optical coherence tomography in clinical practice. High-speed data acquisition is highly reproducible in patients undergoing percutaneous coronary intervention
    Nieves Gonzalo
    Thoraxcenter, Erasmus MC, Rotterdam, Paises Bajos
    Rev Esp Cardiol 63:893-903. 2010
    ..The objective of this study was to assess the reproducibility of FD-OCT systems for characterizing plaque and evaluating stent implantation in patients undergoing a percutaneous coronary intervention...
  66. ncbi Fate of side branches after coronary arterial sirolimus-eluting stent implantation
    Kengo Tanabe
    Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 90:937-41. 2002
    ..Thus, the fate of side branches after SES implantation is favorable and at least as good as after UMS implantation...
  67. ncbi Three-dimensional and quantitative analysis of atherosclerotic plaque composition by automated differential echogenicity
    Nico Bruining
    Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 70:968-78. 2007
    ..To validate automated and quantitative three-dimensional analysis of coronary plaque composition using intracoronary ultrasound (ICUS)...
  68. ncbi Imaging atherosclerotic plaque composition with intracoronary optical coherence tomography
    G van Soest
    Department of Biomedical Engineering, Thorax Center, Erasmus MC, Rotterdam, The Netherlands
    Neth Heart J 17:448-50. 2009
    ..Neth Heart J 2009;17:448-50.)...
  69. ncbi Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up
    Muzaffer Degertekin
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Circulation 106:1610-3. 2002
    ..CONCLUSION: Sirolimus-eluting stents showed persistent inhibition of neointimal hyperplasia for up to 2 years of follow-up...
  70. ncbi TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation
    Kengo Tanabe
    Division of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circulation 107:559-64. 2003
    ..CONCLUSIONS: Paclitaxel-eluting stent implantation is considered safe and potentially efficacious in the treatment of ISR. IVUS guidance to ensure good stent deployment with complete coverage of target lesion may reduce reintervention...
  71. ncbi Invasive imaging technologies: can we reconcile light and sound?
    Evelyn Regar
    Department of Interventional Cardiology, Thoraxcenter, Erasmus, Rotterdam, The Netherlands
    J Cardiovasc Med (Hagerstown) 12:562-70. 2011
    ..They may allow advanced coronary plaque diagnosis in a fast, accurate, reliable, user- and patient-friendly manner and, as such, can help to improve clinical practice today and therapeutic options in the future...
  72. ncbi Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes
    Patrick W Serruys
    Thoraxcenter, Ba 583, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Circulation 122:2301-12. 2010
    ..Nevertheless, late luminal loss was less than that observed with bare metal stents. To maintain the mechanical integrity of the device up to 6 months, the scaffold design and manufacturing process of its polymer were modified...
  73. ncbi A new intracoronary measurement catheter, MetriCath, compared to intravascular ultrasound and quantitative coronary angiography in a stented porcine coronary model
    Willem J van der Giessen
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 57:2-9; discussion 10-1. 2002
    ..Considering the ease and rapidity of obtaining MetriCath results, this technique may form an alternative to the others in evaluating stent expansion. Based on these findings, clinical evaluation seems warranted...
  74. ncbi Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography
    Juan Luis GutiƩrrez-Chico
    Erasmus Medical Centre, Thoraxcenter, Rotterdam, Netherlands
    Circulation 124:612-23. 2011
    ..Whether the neointimal coverage of nonapposed side-branch and ISA struts is delayed with respect to well-apposed struts is unknown...
  75. ncbi Interstudy reproducibility of the second generation, Fourier domain optical coherence tomography in patients with coronary artery disease and comparison with intravascular ultrasound: a study applying automated contour detection
    Z Jamil
    Thoraxcenter, Bd 585, Erasmus MC, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 29:39-51. 2013
    ..No significant differences in quantitative lumen morphometry were observed between FD-OCT and IVUS. Evaluating these results suggest that FD-OCT is a reliable imaging tool to apply in longitudinal coronary artery disease studies...
  76. ncbi No delayed restenosis at 18 months after implantation of sirolimus-eluting stent
    Kengo Tanabe
    Department of Cardiology, Thoraxcenter, University Hospital Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 57:65-8. 2002
    ..This is the first report of angiographic and IVUS images 18 months after the implantation of a sirolimus-eluting stent...
  77. ncbi Sensitivity and specificity of QCA in detecting coronary arterial remodeling after intracoronary brachytherapy: a comparison to serial volumetric three-dimensional intravascular ultrasound analysis. Can we detect positive remodeling by luminography?
    Ken Kozuma
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invasive Cardiol 15:636-40. 2003
    ....
  78. ncbi Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results
    Emanuele Meliga
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    EuroIntervention 4:99-107. 2008
    ..To test the hypothesis that intracoronary infusion of pre-oxygenated HBOC-201 during brief, total coronary artery occlusion would preserve left ventricular function...
  79. ncbi Intracoronary optical coherence tomography and the evaluation of stents
    Peter Barlis
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Expert Rev Med Devices 6:157-67. 2009
    ....
  80. ncbi Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro
    T P M Goderie
    Thorax Center Biomedical Engineering, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 26:843-50. 2010
    ..Typical image artifacts were found to affect the interpretation of OCT data, misclassifying intimal thickening as fibroatheroma or thin-cap fibroatheroma. Adding VH-IVUS to OCT reduced the error rate in this study...
  81. ncbi The diagnostic value of intracoronary optical coherence tomography
    E Regar
    Department of Interventional Cardiology, Thorax Center, Erasmus MC, s Gravendijkwal 230, Rotterdam, The Netherlands
    Herz 36:417-29. 2011
    ..In the future, OCT might emerge, parallel to its undisputed position in research, as the tool of choice in all clinical scenarios where angiography is limited by its nature as a two-dimensional luminogram...
  82. ncbi Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes
    Peter Barlis
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 102:391-5. 2008
    ..In conclusion, detection of TCFA, particularly in stable patients, is desirable and may principally allow for early intervention and prevention of adverse events...
  83. ncbi Local drug delivery using coated stents: new developments and future perspectives
    Kengo Tanabe
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Curr Pharm Des 10:357-67. 2004
    ..This article describe candidate agents which have been tested or currently under investigation, and summarize the latest information...
  84. ncbi [New insights towards catheter-based identification of vulnerable plaque]
    Gaston A Rodriguez-Granillo
    Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Rev Esp Cardiol 58:1197-206. 2005
    ..These new modalities have the potential to provide insights into the pathophysiology of the natural history of coronary plaque by means of prospective studies...
  85. ncbi Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans
    Marco Valgimigli
    Erasmus Medical Center, Thoraxcenter Bd-406, Dr Molewaterplein 40, 3015-GD Rotterdam, The Netherlands
    Eur Heart J 27:655-63. 2006
    ..CONCLUSION: Plaque distance from the coronary ostium, as an independent determinant of relative lipid content, is potentially associated to plaque vulnerability in humans...
  86. ncbi In vivo variability in quantitative coronary ultrasound and tissue characterization measurements with mechanical and phased-array catheters
    Gaston A Rodriguez-Granillo
    Thoraxcenter, Erasmus Medical Center, Bd406, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 22:47-53. 2006
    ..Only limited evaluation of the in vivo agreement of volumetrical measurements between such systems has been performed, despite the fact that such information is essential for the conduction of atherosclerosis regression trials...